Skip to main content
. 2021 Dec 13;11:23874. doi: 10.1038/s41598-021-02534-2

Table 2.

In-Hospital mortality in CHD and Non-CHD patients before and after the PSM.

Statin vs. non-statin Crude mortality rate Unmatched Unmatched Matched
Statin Non-statin p Unadjusted HR.* (95% CI) Statin vs. Nonstatin Adjusted HR. (95% CI) Statin vs. Nonstatin Adjusted HR. (95% CI) Statin vs. Nonstatin
Overall 6.44% 10.88%  < 0.001 0.46 (0.31,0.69) 0.47 (0.29,0.77) 0.13 (0.05,0.36)
CHD 13 (10.4%) 32 (26.0%) 0.001 0.28 (0.15,0.54) 0.46 (0.23,0.90) 0.30 (0.09,0.98)
Non-CHD 13 (4.7%) 265 (10.2%) 0.003 0.35 (0.20,0.62) 0.25 (0.13,0.47) 0.23 (0.1,0.49)

*HR, the hazard ratio of in-hospital mortality between statin and non-statin (reference).